Research Brokerage Updates: HP Inc (NYSE:HPQ), Hologic, Inc. (NASDAQ:HOLX)

For the current quarter, analysts are expecting HP Inc (NYSE:HPQ) to report EPS of $0.39. This consensus estimate is provided by Zacks Research. After the period that ended on 2017-01-31, HP Inc (NYSE:HPQ) reported an EPS actual of $0.38. The difference between the actual and estimate resulted in a surprise factor of 2.7%. The company is expected to release their next earnings report on or around 2017-05-24. Interested parties will be watching to see how company results compare to what the Street was projecting for the fiscal period.

Shares of HP Inc (NYSE:HPQ) have a current ABR or average broker rating of 2.21. This consensus recommendation is also provided by Zacks Research. The recommendation falls on a scale between 1 and 5. A broker rating of 1 would translate into a Strong Buy. A rating of 5 would indicate a Strong Sell recommendation. This consensus broker rating may help shed some light on how the sell-side is currently viewing company stock.

Covering analysts often provide target price projections for company shares. The current Zacks consensus target price on shares of HP Inc (NYSE:HPQ) is $16.541. The top analyst target is $19, and the lowest target is $14 on the stock. Because of the different techniques used to gauge a company target price, estimates may be quite different from one analyst to another.

For the current quarter, analysts are expecting Hologic, Inc. (NASDAQ:HOLX) to report EPS of $0.46. This consensus estimate is provided by Zacks Research. After the period that ended on 2016-12-31, Hologic, Inc. (NASDAQ:HOLX) reported an EPS actual of $0.52. The difference between the actual and estimate resulted in a surprise factor of 1.96%. The company is expected to release their next earnings report on or around 2017-04-26. Interested parties will be watching to see how company results compare to what the Street was projecting for the fiscal period.

Shares of Hologic, Inc. (NASDAQ:HOLX) have a current ABR or average broker rating of 1.73. This consensus recommendation is also provided by Zacks Research. The recommendation falls on a scale between 1 and 5. A broker rating of 1 would translate into a Strong Buy. A rating of 5 would indicate a Strong Sell recommendation. This consensus broker rating may help shed some light on how the sell-side is currently viewing company stock.

Covering analysts often provide target price projections for company shares. The current Zacks consensus target price on shares of Hologic, Inc. (NASDAQ:HOLX) is $44.75. The top analyst target is $51, and the lowest target is $39 on the stock. Because of the different techniques used to gauge a company target price, estimates may be quite different from one analyst to another.

Leave a Comment